| 摘要 |
<p>The invention is concerned with novel heteroaryl carboxamide derivatives of Formula (I), wherein (II), m, X, Y, R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR-2 receptor, CCR-5 receptor and/or CCR-3 receptor and can be used as medicaments.</p> |
| 申请人 |
F. HOFFMANN-LA ROCHE AG;ADAM, JEAN-MICHEL;AEBI, JOHANNES;BINGGELI, ALFRED;GREEN, LUKE;HARTMANN, GUIDO;MAERKI, HANS P.;MATTEI, PATRIZIO;RICKLIN, FABIENNE;ROCHE, OLIVIER |
发明人 |
ADAM, JEAN-MICHEL;AEBI, JOHANNES;BINGGELI, ALFRED;GREEN, LUKE;HARTMANN, GUIDO;MAERKI, HANS P.;MATTEI, PATRIZIO;RICKLIN, FABIENNE;ROCHE, OLIVIER |
